Brief: InflaRx Full Year 2017 Financial & Operating Results
29/03/2018 12:54
March 29 (Reuters) - InflaRx NV IFRX.O :
* INFLARX FULL YEAR 2017 FINANCIAL & OPERATING RESULTS
* INFLARX NV - CASH AND CASH EQUIVALENTS TOTALED EUR 123.3
MILLION
AS OF DECEMBER 31, 2017 COMPARED TO EUR 29.1 MILLION AS OF
DECEMBER 31, 2016
Source text for Eikon: ID:nGNX9H1M1g
Further company coverage: IFRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum